来自SANI注册表的严重喘患者中的固定气道阻塞和支气管扩展剂响应现象
Giuseppe Guida1,2, Francesco Blasi3,4, Giorgio Walter Canonica5,6
1Department of Clinical and Biological Sciences, University of Turin, Turin, Italy giuseppe.guida@unito.it.
BMJ open respiratory research
|October 31, 2025
概括
与可逆气道阻塞 (BDR) 患者相比,患有固定气道阻塞 (FAO) 的严重喘患者表现出不同的临床结果和生物标志物. 在某些晚发性严重喘病例中,粮农组织的这种现象可能是可逆的.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床的表型化 临床的表型化
背景情况:
- 在严重喘 (SA) 中,固定气道阻塞 (FAO) 的定义是不一致的,阻碍了理解.
- 鉴别粮农组织的表型对于了解SA. 很重要.
- 以往关于粮农组织在南非的数据是异质的,因为定义不同.
研究的目的:
- 在意大利严重喘网络 (SANI) 登记册中对FAO严重喘患者进行表征.
- 为了比较SA患者与FAO患者的基线特征和结果,与可逆气道阻塞 (BDR) 患者相比.
- 在随访期间探索FAO或BDR的可逆性潜力.
主要方法:
- 根据粮农组织的定义,使用FEV1/FVC比率< LNN 支气管扩张后,FEV1增加有限 (<12%或200mL).
- 与BDR和无呼吸道阻塞 (无AO) 组的粮农组织患者进行比较.
- 收集关于喘控制 (ACT),生活质量 (AQLQ),恶化 (AEs) 和人口/生物幽默变量的数据.
主要成果:
- 32.8%的SA患者在招募时表现出FAO.
- 粮农组织患者表现出更好的喘控制 (ACT,AQLQ) 和较少的急诊室访问/住院比BDR患者.
- 与BDR患者相比,粮农组织观察到较低的微分呼出氧化 (FeNO) 水平,可能与气道口径有关.
结论:
- 与BDR.相比,SA患者的分层显示出一个独特的FAO表型,与BDR.相比,具有不同的临床结果和生物标记.
- 晚期发病的SA可能是可逆的,特别是在不那么密集的吸入性皮质类固醇治疗中.
- 这项研究强调了精确表型化对于理解和管理严重喘的重要性.
相关概念视频
Physical Assessment of the Respiratory Tract II: Inspection
1.4K
Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
Chest Configuration
The chest configuration...
1.4K
Respiratory System Abnormal Finding I: Inspection and Percussion
1.2K
Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
1.2K
Acute Respiratory Failure-III
1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Acute Respiratory Failure-IV
824
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
824
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Pneumothorax-II
1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.7K


